Science Explorer Back to mapMap
Discussion
Company · Gaithersburg · United States

Univax (United States)

ROR OpenAlex
Research works
4
fractional, all time
Citations
63
17.2 per fractional work
Top-10% rate
0.8%
all institutions 10.0%
Open access
9%
world 40%
International
7%
world 18%
Univax (United States)

Not ranked overall: Univax (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Univax (United States) work in?

In all years, 53% of research at Univax (United States) is in Health Sciences, 47% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (19%). It does 1.3× the world's share of Life Sciences.

Health Sciences: 2 fractional works · 52.8% of its workMedicine: 2 fractional works · 52.8% of its workLife Sciences: 2 fractional works · 47.2% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 27.8% of its workImmunology and Microbiology: 1 fractional works · 19.4% of its workALL ITS WORKUnivax (UnitedStates)4fractional works, all years
Life Sciences47%Health Sciences53%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Medicine252.8%
    1. Biochemistry, Genetics and Molecular Biology127.8%
    2. Immunology and Microbiology119.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Univax (United States)?

The most cited paper from Univax (United States) is "Enzyme‐Linked Immunosorbent Assays ( ELISA )" (Peter V. Hornbeck, Scott Winston, Steven A. Fuller, 1991), with 55 citations. Next come "Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines" (29) and "Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults" (26).

Most cited papers
#PaperReleasedCitations
1 Enzyme‐Linked Immunosorbent Assays ( ELISA ) Peter V. Hornbeck, Scott Winston, Steven A. Fuller · Current Protocols in Molecular Biology Jul 1991 55
2 Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines Richard T. Coughlin, Ali Fattom, Chiayung Chu et al. · Vaccine 1995 29
3 Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults Karen L. Kotloff, Ali Fattom, Lisa Basham et al. · Vaccine Apr 1996 26
4 Immunoblotting and Immunodetection Sean R. Gallagher, Scott Winston, Steven A. Fuller et al. · Current Protocols in Cell Biology Oct 1998 22
5 Staphylococcal Vaccines: A Realistic Dream Ali Fattom, Robert B. Naso · Annals of Medicine 1996 20
All 8 most cited papers, with filters and sorting

Which research topics does Univax (United States) publish most on?

By volume: Glycosylation and Glycoproteins Research, Streptococcal Infections and Treatments, Neonatal and Maternal Infections and Pneumonia and Respiratory Infections.

Glycosylation and Glycop…0Glycosylation and Glycoproteins Research: 0 fractional worksStreptococcal Infections…0Streptococcal Infections and Treatments: 0 fractional worksNeonatal and Maternal Infections: 0 fractional worksPneumonia and Respirator…0Pneumonia and Respiratory Infections: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional worksHIV Research and Treatment0HIV Research and Treatment: 0 fractional worksProtein purification and stability: 0 fractional worksVector-borne infectious diseases: 0 fractional works
Molecular BiologyPublic Health, Environmental and Occupational HealthEpidemiologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  2. 2 Streptococcal Infections and Treatments Public Health, Environmental and Occupational Health 0 works
  3. 3 Neonatal and Maternal Infections Public Health, Environmental and Occupational Health 0 works
  4. 4 Pneumonia and Respiratory Infections Epidemiology 0 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Immune Cell Function and Interaction Immunology 0 works
  7. 7 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  8. 8 HIV Research and Treatment Virology 0 works
  9. 9 Protein purification and stability Molecular Biology 0 works
  10. 10 Vector-borne infectious diseases Parasitology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available9.1%not open90.9%

World: 40% of research is openly available.

with international co-authors6.8%domestic only93.2%

World: 18% is written across borders.

How has Univax (United States)'s research output changed?

1995
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Univax (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.